Teriparatide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Teriparatide and local guidelines before prescribing.

Anabolic bone agent

Mechanism

Recombinant parathyroid hormone fragment (anabolic).

Uses

Severe osteoporosis.

Dosing

Side effects

Nausea, leg cramps, dizziness, hypercalcaemia, injection-site reactions.

Interactions

Digoxin toxicity with hypercalcaemia.

Contraindications and cautions

Hypercalcaemia, Paget disease, previous radiotherapy to skeleton

Monitoring

Calcium

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Avoid in severe renal impairment

Overdose and reversal

Supportive

Special advice

Maximum 24 months; follow with antiresorptive.

More from the textbook: uses, cautions and other points
Where it is discussed in the book